Skip to content

Management of Hypertension through Ayurveda

RANDOMIZED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF GOKSHURADI KWATH AND KAKUBHADI CHURNA IN THE MANAGEMENT OF AAVRIT VYAAN W.S.R. TO ESSENTIAL HYPERTENSION - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081817
Enrollment
60
Registered
2025-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

Ayurvedic and Unani Tibbia College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects willing to participate and able to provide written informed consent. Patient diagnosed as Stage- 1 Essential hypertension would be selected for study on the basis of 8th JNC & WHO criteria.

Exclusion criteria

Exclusion criteria: Patient diagnosed as secondary hypertension or pre-hypertension or taking any Antihypertensive drug. Subjects with any previous Cardiovascular disease or known cases of MI,unstable angina or CHF. Subject suffering from any hepatic disorder (SGPT and SGOT more than two times the upper limit of normal) or Renal dysfunction, uncontrolled Pulmonary dysfunction (asthmatic and COPD subjects).Subjects with current or past diagnosis of malignancy (any malignancy diagnosis in last five years).Subjects who have a recent history or who are currently known to abuse of alcohol or drugs.Subjects suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro-Endocrinal disorders, TB, AIDS etc).Pregnant / Lactating women.Subject on systemic or oral steroids, oral contraceptive pills or estrogen replacement therapy.Subjects who have completed participation in any other clinical trial during the past six (06) months.

Design outcomes

Primary

MeasureTime frame
change in Systolic & Diastolic Blood pressure.Timepoint: Baseline & Day 91

Secondary

MeasureTime frame
change in assessed symptoms of Essential hypertension.Timepoint: Day 1,91

Countries

India

Contacts

Public ContactDr Sujata Yadav

Ayurvedic and Unani Tibbia College and Hospital

sujatakcdelhi@gmail.com9810571653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026